| http://dbpedia.org/ontology/abstract
|
Pegsunercept is a drug for the treatment o … Pegsunercept is a drug for the treatment of rheumatoid arthritis. As of January 2010, Phase II clinical trials have been completed. It is being developed by Amgen. Similarly to etanercept, pegsunercept is a soluble tumor necrosis factor receptor. Pegsunercept is a PEGylated protein.ptor. Pegsunercept is a PEGylated protein.
, ペグスネルセプト(Pegsunercept)は関節リウマチ治療薬のひとつ。2010年1月には、第II相 臨床試験が 完了した。アムジェン社により開発されている。 エタネルセプトと同様に、ペグスネルセプトは可溶性腫瘍壊死因子(TNF-α)受容体である。 ペグスネルセプトはポリエチレングリコールを付加した蛋白質である。
|
| http://dbpedia.org/ontology/casNumber
|
330988-75-5
|
| http://dbpedia.org/ontology/fdaUniiCode
|
Q5I7SFZ853
|
| http://dbpedia.org/ontology/kegg
|
D05393
|
| http://dbpedia.org/ontology/wikiPageID
|
25955992
|
| http://dbpedia.org/ontology/wikiPageLength
|
2155
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
947669372
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Immunosuppressants +
, http://dbpedia.org/resource/Category:Amgen +
, http://dbpedia.org/resource/PEGylated +
, http://dbpedia.org/resource/CD120 +
, http://dbpedia.org/resource/Etanercept +
, http://dbpedia.org/resource/Clinical_trial +
, http://dbpedia.org/resource/Rheumatoid_arthritis +
, http://dbpedia.org/resource/Amgen +
, http://dbpedia.org/resource/Pharmaceutical_drug +
, http://dbpedia.org/resource/Category:TNF_inhibitors +
, http://dbpedia.org/resource/Subcutaneous_injection +
|
| http://dbpedia.org/property/atcPrefix
|
none
|
| http://dbpedia.org/property/bioavailability
|
N/A
|
| http://dbpedia.org/property/c
|
502
|
| http://dbpedia.org/property/casNumber
|
330988
|
| http://dbpedia.org/property/chemspiderid
|
none
|
| http://dbpedia.org/property/h
|
758
|
| http://dbpedia.org/property/kegg
|
D05393
|
| http://dbpedia.org/property/legalStatus
|
investigational
|
| http://dbpedia.org/property/molecularWeight
|
12103
|
| http://dbpedia.org/property/n
|
154
|
| http://dbpedia.org/property/o
|
165
|
| http://dbpedia.org/property/routesOfAdministration
|
http://dbpedia.org/resource/Subcutaneous_injection +
|
| http://dbpedia.org/property/s
|
16
|
| http://dbpedia.org/property/unii
|
Q5I7SFZ853
|
| http://dbpedia.org/property/verifiedfields
|
changed
|
| http://dbpedia.org/property/verifiedrevid
|
458269166
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Keggcite +
, http://dbpedia.org/resource/Template:Drugbankcite +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Cytokine_receptor_modulators +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:As_of +
, http://dbpedia.org/resource/Template:Immunosuppressants +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Antineoplastic-drug-stub +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:TNF_inhibitors +
, http://dbpedia.org/resource/Category:Amgen +
, http://dbpedia.org/resource/Category:Immunosuppressants +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Drug +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Pegsunercept?oldid=947669372&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Pegsunercept +
|
| owl:sameAs |
http://www.wikidata.org/entity/Q7160813 +
, http://vi.dbpedia.org/resource/Pegsunercept +
, http://rdf.freebase.com/ns/m.0b6lk58 +
, http://ja.dbpedia.org/resource/%E3%83%9A%E3%82%B0%E3%82%B9%E3%83%8D%E3%83%AB%E3%82%BB%E3%83%97%E3%83%88 +
, http://fa.dbpedia.org/resource/%D9%BE%DA%AF%D8%B3%D9%88%D9%86%D8%B1%D8%B3%D9%BE%D8%AA +
, https://global.dbpedia.org/id/4tKUo +
, http://yago-knowledge.org/resource/Pegsunercept +
, http://dbpedia.org/resource/Pegsunercept +
|
| rdf:type |
http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/class/yago/Substance100020090 +
, http://dbpedia.org/class/yago/WikicatTNFInhibitors +
, http://dbpedia.org/class/yago/WikicatImmunosuppressants +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://umbel.org/umbel/rc/DrugProduct +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/CausalAgent100007347 +
, http://dbpedia.org/class/yago/Medicine103740161 +
, http://dbpedia.org/class/yago/Inhibitor114724436 +
, http://dbpedia.org/class/yago/Drug103247620 +
, http://dbpedia.org/class/yago/Agent114778436 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/Immunosuppressant103562958 +
|
| rdfs:comment |
Pegsunercept is a drug for the treatment o … Pegsunercept is a drug for the treatment of rheumatoid arthritis. As of January 2010, Phase II clinical trials have been completed. It is being developed by Amgen. Similarly to etanercept, pegsunercept is a soluble tumor necrosis factor receptor. Pegsunercept is a PEGylated protein.ptor. Pegsunercept is a PEGylated protein.
, ペグスネルセプト(Pegsunercept)は関節リウマチ治療薬のひとつ。2010年1月には、第II相 臨床試験が 完了した。アムジェン社により開発されている。 エタネルセプトと同様に、ペグスネルセプトは可溶性腫瘍壊死因子(TNF-α)受容体である。 ペグスネルセプトはポリエチレングリコールを付加した蛋白質である。
|
| rdfs:label |
ペグスネルセプト
, Pegsunercept
|
